FDA Workshop on Drug Development for Chronic Fatigue Syndrome (CFS) and Myalgic Encephalomyelitis (ME)

The public workshop was held on April 25-26, 2013 at the Bethesda Marriott (5151 Pooks Hill Road, Bethesda, MD 20814). On April 25th, FDA gathered patients’ perspectives on CFS and ME through a facilitated group discussion focusing on two main topics:  (1) disease symptoms and daily impacts that matter most to patients; and (2) patients’ perspectives on current approaches to treating CFS and ME. The second day included a scientific discussion with patients, clinicians, researchers and government experts focusing on how to identify quantitative outcome measures to determine if disease symptoms improve with specific drug interventions.


Resources for You

Page Last Updated: 12/11/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.